218 related articles for article (PubMed ID: 1290630)
1. Present status of boron neutron capture therapy.
Carlsson J; Sjöberg S; Larsson BS
Acta Oncol; 1992; 31(8):803-13. PubMed ID: 1290630
[TBL] [Abstract][Full Text] [Related]
2. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.
Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA
Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288
[TBL] [Abstract][Full Text] [Related]
3. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
[TBL] [Abstract][Full Text] [Related]
4. The radiation biology of boron neutron capture therapy.
Coderre JA; Morris GM
Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
[TBL] [Abstract][Full Text] [Related]
5. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
6. [Neutron capturing irradiation: principle, current results and perspectives].
Pignol JP; Chauvel P
Bull Cancer Radiother; 1995; 82(3):283-97. PubMed ID: 8554878
[TBL] [Abstract][Full Text] [Related]
7. In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides.
Fairchild RG; Kahl SB; Laster BH; Kalef-Ezra J; Popenoe EA
Cancer Res; 1990 Aug; 50(16):4860-5. PubMed ID: 2379150
[TBL] [Abstract][Full Text] [Related]
8. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo simulation of the biological effects of boron neutron capture irradiation with d(14)+Be neutrons in vitro.
Pöller F; Sauerwein W
Radiat Res; 1995 Apr; 142(1):98-106. PubMed ID: 7899565
[TBL] [Abstract][Full Text] [Related]
10. Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study.
Matsumura A; Zhang T; Nakai K; Endo K; Kumada H; Yamamoto T; Yoshida F; Sakurai Y; Yamamoto K; Nose T
J Exp Clin Cancer Res; 2005 Mar; 24(1):93-8. PubMed ID: 15943038
[TBL] [Abstract][Full Text] [Related]
11. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
Anticancer Res; 1996; 16(5A):2581-7. PubMed ID: 8917355
[TBL] [Abstract][Full Text] [Related]
12. Microdosimetry for boron neutron capture therapy.
Wuu CS; Amols HI; Kliauga P; Reinstein LE; Saraf S
Radiat Res; 1992 Jun; 130(3):355-9. PubMed ID: 1594762
[TBL] [Abstract][Full Text] [Related]
13. Teatment planning figures of merit in thermal and epithermal boron neutron capture therapy of brain tumours.
Wallace SA; Mathur JN; Allen BJ
Phys Med Biol; 1994 May; 39(5):897-906. PubMed ID: 15552092
[TBL] [Abstract][Full Text] [Related]
14. [Boron neutron capture a a new radiotherapy model].
Hideghéty K; Sauerwwein W; Rassuw J; Sack H
Orv Hetil; 1998 Mar; 139(12):675-9. PubMed ID: 9555163
[TBL] [Abstract][Full Text] [Related]
15. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
16. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
17. Preliminary study for application of anti-alpha-fetoprotein monoclonal antibody to boron-neutron capture therapy.
Takahashi T; Fujii Y; Fujii G; Nariuchi H
Jpn J Exp Med; 1987 Apr; 57(2):83-91. PubMed ID: 2444730
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of 10B in the central degenerative areas of human glioma and colon carcinoma spheroids after sulfhydryl boron hydride administration.
Pettersson OA; Carlsson J; Grusell E
Cancer Res; 1992 Mar; 52(6):1587-91. PubMed ID: 1540968
[TBL] [Abstract][Full Text] [Related]
19. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
20. Physical and tumor biological aspects and calculation model of dosage in boron neutron capture therapy (BNCT).
Rassow J; Pöller F; Steinberg F; Meissner P
Strahlenther Onkol; 1993 Jan; 169(1):7-17. PubMed ID: 8434343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]